Considering the evidence of compartmentalized inflammation, a score was recently calculated based on glial and axonal markers (CHI3L1*GFAP/NfL), known as “Glia score” and related to progressive MS [129]. The gene discussed is NEFL; the disease is myeloid sarcoma.